Navigation Links
50 Pharma Companies Worldwide Now Use Codexis In Process Development
Date:10/24/2011

FRANKFURT, Germany, Oct. 24, 2011 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS) today announced that one year after launch, its Codex® Screening Kits are in use or evaluation in manufacturing process development at 50 pharmaceutical companies worldwide.  The announcement was made at CPhI  Worldwide, a global pharmaceutical ingredients convention meeting here this week.  

Codex® Screening Kits were introduced in October 2010.  Pharmaceutical and fine chemical companies including Merck, Roche, DSM and Dainippon Sumitomo are among the global customers using Codex® Screening Kits and Codex® Panels to reduce pharmaceutical manufacturing process development time and cost.  

Codexis also said that through September 30, 2011, more than 10,000 kilograms of various enzymes used in commercial pharmaceutical intermediates production processes have been manufactured by the company's enzyme production partners. Smaller 10-100 kilogram quantities, also used in processes to make commercial pharmaceutical intermediates, have been manufactured at its Redwood City, CA facility.

"With a global network of production capabilities established, we are supporting our pharmaceutical and fine chemical customers at every scale, from clinical development to commercial production.  This further demonstrates the utility of Codexis biocatalyst enzymes for the development and commercial production of pharmaceutical products," said Peter Strumph, Senior Vice President and Business Head, Pharmaceuticals.

Codexis is an industrial biotechnology company developing products that make manufacturing processes faster, cleaner and cheaper. Codexis' technology is commercialized with leading global pharmaceutical companies and is in development for advanced biofuels with Shell and for biobased chemicals.  For more information, visit www.codexis.com.

Forward-Looking Statements

This press release contains forward-looking statements relating to the utility of Codexis' biocatalyst enzymes for the development and commercial production of pharmaceutical products. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond our control and that could materially affect actual results.  Important factors known to Codexis that could materially affect actual results include Codexis' dependence on contract manufacturers for commercial scale production of its biocatalysts.  Other factors can be found in Codexis' Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 3, 2011, including under the caption "Risk Factors."  Codexis expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.

Contacts:  
Media:  Lyn Christenson, lyn.christenson@codexis.com, 650.421.8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212.827.3771   Investors:  Henk Adriaenssens, ir@codexis.com, 650.421.8331


'/>"/>
SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. S1 Pharmaceuticals Appoints Robert Taylor Segraves, MD, PhD, and Robert Pyke, MD, PhD to Its Scientific Advisory Board
2. Valeant Pharmaceuticals to Announce 2011 Third Quarter Results on November 3, 2011
3. Boca Pharmacal Receives FDA Approval on Glycopyrrolate Tablets
4. Robbins Umeda LLP Announces an Investigation of KV Pharmaceutical Company
5. Cumberland Pharmaceuticals Ranks as one of the Fastest Growing Companies in North America on Deloittes 2011 Technology Fast 500™
6. Onyx Pharmaceuticals Announces Third Quarter 2011 Financial Results Teleconference and Webcast
7. Jazz Pharmaceuticals Announces Third Quarter 2011 Results Conference Call on November 1
8. Arrien Pharmaceuticals Appoints Dr. Philip LoGrasso to its Scientific Advisory Board for CNS/Neurodegenerative Diseases
9. Study Finds Children More Likely to Receive Recommended RSV Medication Doses When Administered Through Specialty Pharmacy
10. Critical Alerts For Intel, Mosaic, Deckers, Foot Locker, and Jazz Pharmaceuticals Released By Seven Summits Research
11. Academy of Managed Care Pharmacy Opens 2011 Educational Conference in Atlanta
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas is ...
(Date:6/23/2016)...  Guerbet announced today that it has been named ... . One of 12 suppliers to receive ... support of Premier members through exceptional local customer service ... to lower costs. ... outstanding customer service from Premier," says Massimo Carrara ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (United States, China, Japan, Brazil, United Kingdom, Germany, France, ... Surgical Procedure Volumes: ... provides surgical procedure volume data in a geographic context. ... analysis of growth drivers and inhibitors, including world population ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best ... individuals in the United States and Canada wear eyeglasses. Once considered to be a ... and make a fashion statement. Even celebrities use glasses as a way of creating ...
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
Breaking Medicine News(10 mins):